Search for: "Hyman, Phelps & McNamara, P.C." Results 101 - 120 of 152
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
When a 510(k) or PMA Goes Off Track – FDA’s Appeals Process
14 Jun 2011, 5:40 am by FDABlog HPM
Hyman, Phelps & McNamara, P.C.'s Jeffrey K. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
ICD2 2012 Conference - Fostering Innovation and Translational Research in Support of Public Health and Economic Growth
28 Nov 2011, 7:26 pm by FDABlog HPM
”  Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
New IP resource for Pharma, Biotech and Chem and You can’t always get what you want – restrictions on remedies in IP litigation
16 Sep 2010, 2:00 am by Duncan
Karst, Hyman, Phelps & McNamara, P.C., United States Klaus Kupka, Taylor Wessing, Germany David C. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
HPMers Slated to Speak at FDLI’s Enforcement, Litigation and Compliance Conference
30 Nov 2023, 8:44 pm by Hyman Phelps McNamara
The 2023 Food and Drug Law Institute’s (“FDLI”) Enforcement, Litigation and Compliance Conference will boast two speakers from Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
ACI’s 40th FDA Boot Camp – March 22-23, 2023 (Virtual)
2 Jan 2023, 7:14 pm by Hyman Phelps McNamara
Karst (Director, Hyman, Phelps & McNamara P.C.). [read post]
FDA Law Blog - https://www.thefdalawblog.com/
JOIN HP&M FOR A WEBINAR: “The ‘End’ of the COVID-19 Emergency: The Ryan Haight Act, Telemedicine, and Next Steps?” on Thursday, March 23, 2023 at 12 Noon EST
12 Mar 2023, 7:20 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
14th Asia Pacific Symposium on Cochlear Implant and Related Sciences Set to Convene in Seoul — Featuring HP&M’s Dr. Philip Won
5 Nov 2023, 7:32 pm by Hyman Phelps McNamara
Philip Won, of Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
ACI’s 42nd FDA Boot Camp – New York City Edition
24 Jan 2024, 2:48 am by Hyman Phelps McNamara
Karst (Director, Hyman, Phelps & McNamara, P.C.) and Stacy Cline Amin (Partner, Morrison & Foerster (Former Chief Counsel, U.S. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Congratulations to HP&M’s first Principal Medical Device Regulation Expert, Adrienne Lenz
5 Jan 2022, 12:00 am by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
FDASIA Enacted; HP&M Issues Detailed Summary and Analysis
11 Jul 2012, 1:25 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C. has prepared a detailed summary and analysis of FDASIA. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
“Thaw Out” with Pharma Thought Leaders at the 2024 Puerto Rico Pharmaceutical Summit: HPM Directors to Discuss Drug Approvals and Puerto Rico “Exportation” Best Practices
11 Jan 2024, 7:22 pm by Hyman Phelps McNamara
Two Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
HP&M’s James Valentine & Ellis Unger @ DIA 2022: FDA Rare Disease Town Hall with CDER & CBER Center Directors, Optimizing Benefit-Risk Assessments, Reflecting on 10 Years of PFDD
2 Jun 2022, 8:02 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
New IP resource for Pharma, Biotech and Chem Finding the right model for Research & Development Collaboration
20 Jun 2011, 10:15 pm by Duncan
Karst, Hyman, Phelps & McNamara, P.C., United States Klaus Kupka, Taylor Wessing, Germany David C. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
HP&M Attorneys Receive Accolades: Top Lawyer Under 40 and WWL: Life Sciences 2023 Global Elite Thought Leader
27 Jun 2023, 2:29 am by Hyman Phelps McNamara
Valentine Named Top Lawyer Under 40; Only Food and Drug Lawyer Selected Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
FDLI Conference – Brands, Generics and Hatch-Waxman: New Challenges; Unabated Controversy
7 Jun 2011, 10:15 am by FDABlog HPM
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
CMS Physician Sunshine Proposal Finally Sees Light of Day; HP&M Issues Summary Memorandum
22 Dec 2011, 5:48 pm by FDABlog HPM
  Hyman, Phelps & McNamara, P.C. has prepared a summary of the proposed rule, which is available here. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
New IP resource for Pharma, Biotech and Chem – Licensing and listing
7 Mar 2011, 9:38 pm by Duncan
Karst, Hyman, Phelps & McNamara, P.C., United States Klaus Kupka, Taylor Wessing, Germany David C. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements
21 Mar 2011, 9:14 pm by Duncan
Karst, Hyman, Phelps & McNamara, P.C., United States Klaus Kupka, Taylor Wessing, Germany David C. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
New IP resource for Pharma, Biotech and Chem – Tie-in / tie-out clauses and competition
18 Apr 2011, 10:12 pm by Marie Louise
Karst, Hyman, Phelps & McNamara, P.C., United States Klaus Kupka, Taylor Wessing, Germany David C. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
New IP resource for Pharma, Biotech and Chem – Confidential information protection and jurisdictional differences
18 May 2011, 9:45 pm by Duncan
Karst, Hyman, Phelps & McNamara, P.C., United States Klaus Kupka, Taylor Wessing, Germany David C. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog